Analyst Consensus ?
ConsensusBuy31 ratings
Bullish1858.1%
Neutral1238.7%
Bearish13.2%
1 unmapped firm rating excluded from the percentages.
Regency Centers Corporation · REG · FY2024 Q4 · Calendar Q1 2025
Regency Centers pairs strong leasing with a $500 million pipeline
The call supports a constructive but qualified view: tenant demand, leasing execution, and development may support growth, while credit loss, cost, rate, and occupancy risks remain important tests.
Reported After market closeNASDAQReal Estate
$13.55B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.48
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $357.7M
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+1.5%
Event window
SPY move
-0.9%
Same window
Abnormal move
+2.4%
Stock minus SPY
Volume
1.5×
Versus trailing sessions
Subsequent drift
-0.1%
Up to 20 sessions
REGSPY benchmark
Ask FN2 about REG FY2024 Q4
Transcript, numbers and history already loaded
What drove REG's +1.5% move after FY2024 Q4 earnings?What changed in REG's guidance and outlook in FY2024 Q4?Give me the bull and bear case for REG after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior analysis, the current call showed 3.6% same-property NOI growth versus 4.9% previously, maintained guidance rather than raising it, and described a pipeline near $500 million with approximately $250 million of 2025 starts.
Guidance delta
Management maintained guidance; 2025 FFO guidance was set at $4.52–$4.58 per share, implying roughly 6% growth.
Key takeaways
- Same-property NOI grew 3.6% year over year, driven by base-rent growth and higher rent spreads.
- Record leasing activity and 96.7% same-store lease rate support the near-term operating backdrop.
- The development and redevelopment pipeline is near $500 million, with approximately $250 million of 2025 starts planned.
Management priorities
- Execute the development and redevelopment pipeline.
- Pursue high-yield grocery-anchored projects and selected acquisitions.
- Maintain dividend growth and opportunistic share repurchases.
Follow REG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$73.98Current
$60Low
$80.59Average
$92High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 9, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 28, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Sep 24, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Sep 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Sep 21, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Sep 17, 2026 |
| Ladenburg Thalmann | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 5, 2026 |
| Truist Securities | Buy | Buy | Maintain | Mar 2, 2026 |
| Keybanc | Overweight | Downgrade | Dec 4, 2025 | |
| Baird | Outperform | Outperform | Maintain | Jul 30, 2025 |
| BTIG | Buy | Buy | Maintain | Nov 27, 2024 |
| Deutsche Bank | Hold | Buy | Downgrade | Sep 26, 2024 |
| Compass Point | Buy | Buy | Maintain | Sep 10, 2024 |
| Raymond James | Outperform | Outperform | Maintain | Aug 16, 2024 |
| Jefferies | Buy | Buy | Maintain | Mar 7, 2024 |
| Argus Research | Buy | Hold | Upgrade | Sep 20, 2023 |
| B of A Securities | Buy | Buy | Maintain | Aug 22, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jun 23, 2022 |
| BMO Capital | Outperform | Market Perform | Upgrade | Dec 1, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 21, 2020 |
| RBC Capital | Outperform | Top Pick | Downgrade | Dec 14, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| BTIG Research | Buy | Neutral | Upgrade | Jan 29, 2018 |
| Boenning & Scattergood | Neutral | Underperform | Upgrade | Oct 3, 2017 |
| Roth Capital | Buy | Buy | Maintain | Apr 1, 2016 |
| Bank of America | Buy | Neutral | Upgrade | Dec 4, 2014 |
| ISI Group | Neutral | Buy | Downgrade | Dec 17, 2013 |
| Janney Capital | Neutral | Neutral | Maintain | Sep 10, 2013 |
| Goldman Sachs | Sell | Sell | Maintain | May 9, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $73.98. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | James Feldman | $84 | $74.38 | +13.5% | Oct 23, 2026 |
| UBS | Analyst unavailable | $77 | $71.47 | +4.1% | Oct 9, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $71.42 | +17.6% | Oct 5, 2026 |
| Truist Financial | Analyst unavailable | $84 | $71.8 | +13.5% | Oct 1, 2026 |
| Barclays | Richard Hightower | $85 | $73.23 | +14.9% | Sep 28, 2026 |
| Goldman Sachs | Analyst unavailable | $83 | $72.73 | +12.2% | Sep 24, 2026 |
| Griffin | Michael Griffin | $81 | $73.04 | +9.5% | Sep 21, 2026 |
| Scotiabank | Nicholas Yulico | $81 | $73.04 | +9.5% | Sep 17, 2026 |
| Barclays | Analyst unavailable | $92 | $76.71 | +24.4% | Aug 17, 2026 |
| Argus Research | Analyst unavailable | $85 | $76.15 | +14.9% | Aug 10, 2026 |
| Evercore ISI | Analyst unavailable | $83 | $80.06 | +12.2% | Jul 30, 2026 |
| Wells Fargo | Jamie Feldman | $90 | $82.22 | +21.7% | Jul 23, 2026 |
| UBS | Analyst unavailable | $85 | $79.72 | +14.9% | Jul 9, 2026 |
| Evercore ISI | Steve Sakwa | $81 | $80.87 | +9.5% | Jul 7, 2026 |
| Raymond James | Analyst unavailable | $88 | $81.68 | +19.0% | Jun 29, 2026 |
| BTIG | Analyst unavailable | $85 | $80.69 | +14.9% | Jun 12, 2026 |
| Deutsche Bank | Analyst unavailable | $85 | $78.52 | +14.9% | May 29, 2026 |
| Wells Fargo | Analyst unavailable | $88 | $78.84 | +19.0% | May 26, 2026 |
| UBS | Analyst unavailable | $81 | $77.33 | +9.5% | May 18, 2026 |
| Barclays | Richard Hightower | $90 | $77.72 | +21.7% | May 12, 2026 |
| Evercore ISI | Analyst unavailable | $80 | $77.59 | +8.1% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $84 | $76.81 | +13.5% | Feb 10, 2026 |
| Deutsche Bank | Omotayo Okusanya | $83 | $71.47 | +12.2% | Jan 20, 2026 |
| UBS | Analyst unavailable | $76 | $69.52 | +2.7% | Jan 14, 2026 |
| Mizuho Securities | Analyst unavailable | $74 | $70.62 | +0.0% | Jan 9, 2026 |
| UBS | Analyst unavailable | $74 | $70.62 | +0.0% | Jan 9, 2026 |
| UBS | Michael Goldsmith | $75 | $69.99 | +1.4% | Jan 8, 2026 |
| Morgan Stanley | Ronald Kamdem | $85 | $68.09 | +14.9% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $79 | $68.24 | +6.8% | Dec 15, 2025 |
| Wells Fargo | Analyst unavailable | $82 | $72.21 | +10.8% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $83 | $71.68 | +12.2% | Oct 6, 2025 |
| Scotiabank | Nicholas Yulico | $76 | $71.58 | +2.7% | Aug 28, 2025 |
| Truist Financial | Ki Bin Kim | $81 | $71.02 | +9.5% | Aug 15, 2025 |
| Wells Fargo | Dori Kesten | $79 | $72.83 | +6.8% | Mar 26, 2025 |
| Scotiabank | Analyst unavailable | $80 | $76.7 | +8.1% | Feb 28, 2025 |
| KeyBanc | Todd Thomas | $80 | $72.28 | +8.1% | Nov 4, 2024 |
| Evercore ISI | Steve Sakwa | $77 | $71.75 | +4.1% | Oct 29, 2024 |
| Deutsche Bank | Derek Johnston | $75 | $71.85 | +1.4% | Sep 26, 2024 |
| Evercore ISI | Samir Khanal | $75 | $74.68 | +1.4% | Sep 16, 2024 |
| Truist Financial | Ki Bin Kim | $78 | $70.01 | +5.4% | Aug 15, 2024 |
| Truist Financial | Ki Bin Kim | $70 | $60.61 | -5.4% | May 20, 2024 |
| Scotiabank | Greg McGinnis | $65 | $60.42 | -12.1% | May 16, 2024 |
| Mizuho Securities | Haendel Juste | $60 | $57.29 | -18.9% | Apr 18, 2024 |
| Wells Fargo | Dori Kesten | $70 | $62.9 | -5.4% | Mar 5, 2024 |
| Evercore ISI | Steve Sakwa | $71 | $62.97 | -4.0% | Jan 22, 2024 |
| Morgan Stanley | Ronald Kamdem | $75 | $65.54 | +1.4% | Dec 21, 2023 |
| Barclays | Ross Smotrich | $71 | $67.02 | -4.0% | Dec 18, 2023 |
| BTIG | Michael Gorman | $77 | $71.15 | +4.1% | Dec 15, 2021 |
| Evercore ISI | Samir Khanal | $82 | $71.81 | +10.8% | Dec 6, 2021 |
| Barclays | Anthony Powell | $78 | $73.35 | +5.4% | Nov 17, 2021 |
Track every rating change on REG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRegency Centers is recognized as a leading national entity specializing in the ownership, management, and development of retail complexes. These properties are strategically located in prosperous and densely populated market regions. The company's portfolio showcases a collection of thriving sites, expertly curated with high-performing supermarkets, popular eateries, essential service businesses, and premier retailers, all deeply integrated with their local neighborhoods, communities, and clientele. Operating as a comprehensive real estate firm, Regency Centers is a qualified Real Estate Investment Trust (REIT), characterized by its self-administered and self-managed structure, and is a respected constituent of the S&P 500 Index.
Historical context
All REG earningsReal Estate peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| RITM-PD Rithm Capital Corp. | FY2026 Q3 · Calendar Q4 2026 | +10.2% | — | Rithm highlights servicing, inflows and technology-led efficiency |
| CBRE CBRE Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.6% | -2.5% | CBRE: Infrastructure Growth Offsets Capital-Markets Headwinds |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the REG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-23T00:02:36.799981+00:00
- Polygon adjusted daily market bars · 2026-10-24T22:00:41.470943+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T22:00:41.468172+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.